Menu

Pancreatic Cancer: Types, Risk Factors, Symptoms: Publications and Documents

Summary

The Disabled World section on pancreatic cancer offers a comprehensive collection of articles and papers covering various aspects of this disease. These publications explore topics such as different types of pancreatic cancer, risk factors, diagnostic methods, and treatment options. The database includes peer-reviewed research, clinical studies, and informative pieces that provide valuable insights for patients, caregivers, and healthcare professionals. For example, readers can find information on the latest advancements in early detection techniques, the role of genetic factors in pancreatic cancer development, and emerging therapies like immunotherapy. This resource is particularly beneficial for individuals with disabilities, seniors, and their families, as it offers information to help them better understand and navigate the challenges associated with pancreatic cancer.

Searching the Database

The data table below lists items that may have been updated or revised, but the table defaults to sorting by descending publication date; you can search and sort by clicking column headers (JavaScript required). Items in this category are also distributed via our Pancreatic Cancer: Types, Risk Factors, Symptoms RSS feed.

Pancreatic Cancer: Types, Risk Factors, Symptoms: Publications and Resources (25 Items)
Title and DescriptionEdPublish
Revised

A clinical trial will examine if chemotherapy followed by a novel surgical procedure can improve outcomes for patients with pancreatic tumors previously considered inoperable.


Study reveals the details of two key transition points in the development of pancreatic cancer and provides insights into treatment resistance and how immunotherapy could be used to treat this tumor type.


New study shows that stress accelerates the development of pancreatic cancer by triggering the release of fight or flight hormones.

Patients with pancreatic cancer may soon face better treatment options due to a discovery by Dr. Reginald Hill, Archibald Assistant Professor of Cancer Biology.


Clinical trial for pancreatic cancer shows experimental therapy can control tumors enough to make some patients eligible for surgery.

Study indicates pancreatic cancer will surpass breast and colorectal cancer to become the second leading cause of cancer-related death in the U.S. around 2020.


Researchers have developed a new method which can predict with 97% certainty which pancreatic cysts constitute precursors to cancer.

Examines whether patients should spend a large amount of the time they have left undergoing aggressive treatment for only a brief period of additional life.

Calls attention to lack of federal resources allocated to pancreatic cancer research and supports need for legislation as lawmakers re-introduce the Pancreatic Cancer Research & Education Act.

Pancreatic cancer action network announces new initiative to double the survival rate for pancreatic cancer patients by 2020.

Scientists have deciphered the genetic code for a type of pancreatic cancer called neuroendocrine or islet cell tumors.

Cancer researchers at the Peggy and Charles Stephenson Oklahoma Cancer Center have found a way to stop early stage pancreatic cancer in research models.

Research reveals pancreatic cancer progresses slowly, opening possibility for earlier diagnosis and treatment, crucial for at-risk groups like seniors and the disabled.



Many pancreatic tumors are slow growing taking nearly 20 years to become lethal after the first genetic perturbations appear.

Drinking two or more soft drinks a week more than doubles the risk of developing pancreatic cancer.

Salirasib has shown positive results against pancreatic cancer and recently passed clinical trials.


High intake of dietary fats from red meat and dairy products associated with an increased risk of pancreatic cancer.

Meat cooked at high temperatures to the point of burning and charring may increase the risk of developing pancreatic and other cancers.


A combination of two targeted therapies packs a powerful punch to kill pancreatic cancer cells in the laboratory.

Smoking appears to be associated with an increased risk of acute and chronic pancreatitis.


Experimental technique safely differentiates patients with pancreatic cancer precursor lesions and benign tumors.


Researchers have developed a way to examine cell biopsies and detect signs of early stage pancreatic cancer.


Abnormalities in genes that repair DNA replication may help identify people at high risk of developing pancreatic cancer.

Pancreatic cancer is the deadliest of all cancers only five out of a hundred people who suffer from pancreatic cancer will live more than five years.


Patrick Swayze was diagnosed with pancreatic cancer in January 2008 and has been undergoing chemotherapy at the Stanford University Medical Center.

Key: the first check mark indicates the publication carries an editor's note; the second indicates a footnote.

Note: Disabled World compiles disability-related publications as a resource. Inclusion does not imply endorsement by Disabled-World.com. To submit disability-related articles and peer-reviewed manuscripts and papers, ensure submissions comply with our guidelines. For questions, please contact us.

Back to Pancreatic Cancer: Types, Risk Factors, Symptoms Index.

Share This Information

Permalink:

Database of <a href="https://www.disabled-world.com/health/cancer/pancreatic-2/">Pancreatic Cancer: Types, Risk Factors, Symptoms documents, papers, and peer reviewed publications</a> - Disabled World (DW).

While we strive to provide accurate, up-to-date information, our content is for general informational purposes only. Please consult qualified professionals for advice specific to your situation.